Discussion about this post

User's avatar
for the kids's avatar

There is a recent BMJ about US organizations not responding adequately to the Cass Review. The AAP saying, oh, look at what the red states are doing rather than comparing to what they are doing, and the Endocrine Society, which I think also wrote the AMA guidelines, saying the studies haven't changed...well...the studies they used in their 2017 guidelines were de Vries 2011 and 2014 for benefit and the understanding of those has changed, since the first failed replication, the second measured an improvement but changed the scales and the long term outcomes of several in this treatment plan are now becoming known and don't look great even for the majority of MTF, Abbruzzese et al., 2024.

But there is also a great quotation in there:

"“The Cass report is going to stand the test of time,” says Erica Anderson, a clinical psychologist and former president of the US Professional Association for Transgender Health. “I’m already hearing from the boards of directors and trustees of some hospital systems who are starting to get nervous about what they’ve permitted. So I think that’s going to accelerate change within American healthcare.”"

https://www.bmj.com/content/385/bmj.q1141

Some doctors I am talking with are sure this is a field of medicine that is just being scrutinized too closely because people have ulterior motives. When they find out that it is not actually medicine, they are shocked. It is being done in their name and they are angry. I hope they start speaking up.

Expand full comment
LAMacroGuy's avatar

Not sure how I missed this post. It is fascinating. Any hope detransitioners can file a class action lawsuit?

Expand full comment
2 more comments...

No posts

Ready for more?